How the genome activates or silences transcriptional programmes governs organ 23 formation. Little is known in human embryos undermining our ability to benchmark the 24 fidelity of in vitro stem cell differentiation or cell programming, or interpret the pathogenicity 25 of noncoding variation. Here, we studied histone modifications across thirteen tissues during 26 human organogenesis. We integrated the data with transcription to build the first overview of 27 how the human genome differentially regulates alternative organ fates including by 28 repression. Promoters from nearly 20,000 genes partitioned into discrete states without 29 showing bivalency. Key developmental gene sets were actively repressed outside of the 30 appropriate organ. Candidate enhancers, functional in zebrafish, allowed imputation of 31 tissue-specific and shared patterns of transcription factor binding. Overlaying more than 700 32 noncoding mutations from patients with developmental disorders allowed correlation to 33 unanticipated target genes. Taken together, the data provide a new, comprehensive genomic 34 framework for investigating normal and abnormal human development. 35
INTRODUCTION

36
Organogenesis is the key phase when the body's tissues and organs are first assembled from 37 rudimentary progenitor cells. In human embryos this is the critical period during weeks five to eight 38 of gestation when disruption can lead to major developmental disorders. While approximately 35% 39 of developmental disorders are explained by damaging genetic variation within the exons of 40 protein-coding genes 1 , de novo mutation (DNM) in the noncoding genome has been associated 41 increasingly with major developmental disorders 2 . The noncoding genome also harbours over 80% 42 of single nucleotide polymorphisms (SNPs) implicated in genome wide association studies 43 (GWAS) for developmental disorders, or in GWAS of later onset disease, such as schizophrenia and 44 type 2 diabetes, where contribution is predicted from early development 3 . These genetic alterations 45 are presumed to lie in enhancers for developmental genes or in other regulatory elements such as 46 promoters for noncoding RNAs that may only be active in the relevant tissue at the appropriate 47 stage of organogenesis. Aside from rare examples 4 , this has remained unproven because of lack of 48 data in human embryos. While regulatory data are available in other species at comparable stages 5 , 49 extrapolation is of limited value because the precise genomic locations of enhancers are poorly 50 conserved 6,7 even allowing for enriched sequence conservation around developmental genes 8,9 . 51 Sequence conservation alone is also uninformative for when and in what tissue a putative enhancer 52 might function. Comprehensive regulatory information is available from later fetal development via 53 initiatives such as NIH Roadmap 10 but these later stages largely reflect terminally differentiated, 54 albeit immature cells rather than progenitors responsible for organ formation. In contrast, a small 55 number of studies on a handful of isolated tissues, such as limb bud 11 , craniofacial processes 12 , 56 pancreas 13 or brain 14 , have demarcated regulatory elements directly during human organogenesis. 57
However, most organs remain unexplored. Moreover, nothing is known about patterns of regulation 58 deployed across tissues, which is an important factor because tissues are often co-affected in 59 developmental disorders. To address these gaps in our knowledge we set out to build maps of 60 genome regulation integrated with transcription during human organogenesis at comprehensiveness 61 currently unattainable from single cell analysis. 62
RESULTS
63
Organs and tissues from thirteen sites were microdissected and subjected to chromatin 64 immunoprecipitation followed by deep sequencing (ChIPseq) for three histone modifications 65 ( Figure 1a ): H3K4me3, enriched at promoters of transcribed genes; H3K27ac, at active enhancers 66 and some promoters; and H3K27me3 delineating regions of the genome under active repression by 67
Polycomb. Tiny tissue size and the scarcity of human embryonic tissue required some pooling and 68 precluded study of additional modifications. Biological replicates were undertaken for all but two 69 tissue sites ( Supplementary Table 1 ). Tissues and stages were matched to polyadenylated RNAseq 70 datasets acquired at sufficient read depth to identify over 6,000 loci with previously unannotated 71 transcription ( Supplementary table 2) 15 . Overlaying the data revealed characteristic tissue-specific 72 patterns of promoter and putative enhancer activity, and novel human embryonic transcripts. This 73 was particularly noticeable surrounding genes encoding key developmental transcription factors 74 (TFs), such as the example shown for NKX2-5 in heart (Figure 1b ). Tissues lacking expression of 75 the TF gene tended to carry active H3K27me3 modification (rather than simply lack marks). 76
Putative tissue-specific enhancer marks were characteristically distributed over several hundred 77 kilobases (heart-specific example to the far right of Figure 1b ). These isolated H3K27ac marks were 78 often unpredicted by publically available data from cell lines or terminally differentiated lineages 79 and were not necessarily conserved across vertebrates (mean per-base phyloP score 0.175; range -80 1.42 to +6.94 for n=51,559 regions) 16 . Unexpected H3K4me3 and H3K27ac peaks that failed to 81 map to the transcriptional start sites (TSSs) of annotated genes mapped to the TSS of novel human 82 embryo-enriched transcripts, such as the bidirectional HE-TUCP-C5T408 and HE-LINC-C5T409 83 had both H3K4me3 and H3K27me3 marks with some detection of H3K27ac (State 8; range 0.16-92 0.33). This latter state has been considered bivalent and characteristic of 'poised' genes whose 93 imminent expression then initiates cell differentiation pathways [18] [19] [20] . Ascribing bivalency has been 94 reliant on setting an arbitrary threshold for whether a site is marked or not, and might simply reflect 95 mixed marks due to heterogeneity in a cell population. To avoid the need for thresholding we 96 clustered promoter profiles for each histone mark integrated with transcription over 3 kb either side 97 of 19,791 distinct protein-coding TSS in each tissue 21 (Figure 2 and Supplementary figures 2-4). 98
Broader H3K4me3 and H3K27ac signals at the TSS correlated with higher levels of transcription 99 (Figure 2a-b; we termed this promoter state 'Broad' expressed versus 'Narrow' or 'Bi-directional' 100 expressed). 25-30% of genes across tissues were unmarked and lacked appreciable transcription 101 ('Inactive'). These promoters typically lacked CpG islands (<20% compared to 67.7% of the 19,791 102 genes). Conversely, 90-95% of TSS regions marked with H3K27me3 featured CpG islands with an 103 over-representation of TFs; 31.2% of TFs (n=1,659) were actively repressed in at least one tissue 104 compared to 20.0% of non-TF genes (odds ratio 1.82, confidence interval 1.63-2.04; p-value <2.2e-105 16). H3K27me3 detection at the TSS was ~50% greater for genes encoding TFs (Supplementary 106 figure 5). H3K27me3 was only detected with minimal accompaniment of H3K4me3 or H3K27ac 107 and no transcription ( Figure 2 a-b ). The categorization for each of the 19,791 genes in all tissues is 108 listed in Supplementary table 3. This neat partitioning would not have been possible if the data were  109 overly confounded by cellular heterogeneity. The data argue against a major bivalent chromatin 110 state at gene promoters in progenitor cells during human organogenesis. 111
This classification allowed us to ask how promoter state changed across different tissues. 112
Tracking all states in all tissues was complex to visualise (Supplementary figure 6). Unifying 113 'Broad', 'Narrow' and 'Bi-directional' expressed into a single category ('Expressed') displayed 114 how the majority of genes remained unaltered across the thirteen tissues ( Figure 3a ). In contrast, 115 29% of genes had a variable promoter state. Within this subset we predicted that genes responsible 116 for a specific organ's assembly, such as developmental TFs, would need to be actively excluded or 117 'disallowed' at inappropriate sites (as seen in Figure 1b for NKX2-5). We tested this in the 118 replicated datasets by comparing genes transcribed uniquely in one tissue for either inactivity (no 119 mark) or active repression elsewhere (H3K27me3; disallowed). Gene ontology (GO) analysis of the 120 'uniquely expressed/disallowed elsewhere' gene sets identified the appropriate developmental 121 programme in all instances (as shown for heart in Figure 3b ; e.g. 'heart development'). In contrast, 122 tissue-specific transcription initiated from genes that were simply inactive in other organs tended to 123 highlight differentiated cell function ( Figure 3b ; e.g. sarcomere organization). These observations 124 highlight the preferential use of H3K27me3 at the promoters of genes controlling cell fate decisions 125 but not differentiated function. To study this over time, we included datasets from human 126 pluripotent stem cells (hPSCs) and adult tissue, to scrutinize regulatory changes temporally. 127 Different sets of repressed genes lost their H3K27me3 mark to become expressed as cells 128 transitioned from pluripotency to embryonic pancreatic progenitors or from pancreatic progenitors 129 to mature pancreas ( Figure 3c) . Surprisingly, the same KEGG term relating to monogenic diabetes 130 emerged in both instances ( Figure 3d ). However, the genes underlying the first transition related to 131 early function in pancreatic organogenesis, hypoplasia or aplasia; while the genes in the second 132 transition specifically related to post-embryonic pancreatic islet cell differentiation and beta-cell 133 function 22 . 134
Having recognized the disallowed status of developmental TFs in inappropriate tissues, we 135 wanted to test whether our putative intergenic human embryo-enriched enhancers were capable of 136 driving appropriate reporter gene expression at the correct locations in developing zebrafish. We 137 identified H3K27ac marks that were enriched in the human embryo compared to 161 ENCODE or 138 NIH Roadmap datasets 10,23 and not detected in the FANTOM5 project 24 . We developed an 139 algorithm to test for embryonic tissue specificity and filtered for sequence conservation (not 140 necessarily in zebrafish; see Materials & Methods). We manually inspected the remainder for 141 proximity (<1 mb) to genes encoding TFs and, in particular, to increase clinical relevance, to those 142 associated with major developmental disorders. We ensured no H3K4me3 or polyadenylated 143 transcription in the immediate vicinity (i.e. an unannotated promoter). We tested ten such enhancers 144 out of 44 within 1 mb of TBX15, HEY2, ALX1, IRX4, PITX2, HOXD13, NKX2-5, WT1, SOX11 and 145 SOX9 for their ability to direct appropriate GFP expression in stable lines of transgenic zebrafish 146 ( Supplementary table 4 ). Two (h-003-kid near WT1 and h-022-mix near SOX11) failed to generate 147 any GFP in any location. The remaining eight all yielded GFP at the predicted site in zebrafish 148 embryos ( Figure 4 and Supplementary table 4 ), despite only one of the putative enhancer sequences 149 being conserved in zebrafish ( Fig. 4a , h-027-lim near TBX15). These data imply that our H3K27ac 150 detection marks novel functional enhancers operating over considerable distance. Moreover, inter-151 species sequence conservation is not needed for appropriate reporter gene expression (i.e. it is the 152 TFs which bind that are conserved). 153
We wanted to explore the link between these regulatory elements and surrounding gene 154 expression at genome-wide scale. Assured that ChIPseq marks were reproducible within biological 155 replicates without batch effect (Supplementary figure 7) we parsed the genome into 3,087,584 non-156 overlapping 1 kb bins. Reads within each bin were counted for each mark. Phi correlation between 157 biological replicates indicated this approach to peak calling was very similar to using MACS 158 congenital heart disease 25 . Having integrated our data we could also uncover regulatory regions that 180 were shared precisely across two or more tissues to explore developmental disorders which 181 manifest in multiple organs. Novel enrichment for composite PITX1/bHLH motifs was found in 182 limb and palate ( Figure 5c ). GATA binding motifs were enriched in heart and pancreas. Shared 183 patterns could be explicitly instructed by requiring detection in four or more samples 184 (Supplementary figure 12 ). We hypothesized that patterns shared across many tissues ought to were marked by H3K27ac and/or H3K4me3 that was replicated in at least one tissue. Most 202 commonly, this included the heart or brain, in keeping with the predominance of 203 neurodevelopmental and cardiac phenotypes in the DDD cohort and the PHEs selected for 204 sequencing (Figure 6c ). 75% of the PHEs with DNMs mapped to replicated H3K27ac and/or 205 H3K4me3 in our heart dataset. This rose to 100% if the need for replication was removed. We did 206 not observe enrichment for DNMs in patients with heart or limb phenotypes in elements marked by 207
H3K27ac but the power of this test was most likely hampered by low patient numbers (Figure 6d ). 208
Enrichment for DNMs in elements marked by H3K27ac was detected for the greater number of 209 cases with neurodevelopmental disorders (1.45-fold, 95% confidence interval 1.09-1.90; p=0.0056) 210 ( Figure 6d ). This was similar to our previous report using NIH Roadmap H3K27ac and/or DNaseI 211 hypersensitivity data derived from second trimester fetal brain 2 . Our results support a role for non-212 coding mutations in severe neurodevelopmental disorders and that regulatory marks active during 213 human organogenesis could help stratify disease-relevant non-coding regions. 214
Prioritising DNMs for potential pathogenicity and how they might disrupt surrounding gene 215 function is very challenging. For developmental disorders our mapping allowed focus on enhancers 216 and promoters in the relevant tissue at an appropriate embryonic stage. Our comprehensive tissue-217 by-tissue catalogue of transcription also allowed more detailed consideration of DNMs in close 218 proximity to previously unappreciated human embryonic noncoding RNAs. Correlating histone 219 modifications with gene expression across all tissues offered a means of prioritising target gene(s). 220
As an example, we identified a G-to-T DNM in a patient with a neurodevelopmental disorder in a 221 and individual tissues and organs were immediately dissected (Supplementary table 1) . The material 291 collected here for epigenomic analysis was matched to material isolated for a previous 292 transcriptomic study 15 and the dissection process was identical. In brief, the pancreas, adrenal gland, 293 whole brain, heart, kidney, liver, limb buds, lung, stomach, and anterior two-thirds of the tongue 294 were visible as discrete organs and tissues. All visible adherent mesenchyme, including capsular 295 material (adrenal), was removed under a dissecting microscope. The ureter was removed from the 296 renal pelvis. A window of tissue was removed from the lateral wall of the left ventricle of the heart. 297
The dissected segment of liver avoided the developing gall bladder. The trachea was removed 298
where it entered the lung parenchyma. The stomach was isolated between the gastro-oesophageal 299 and pyloric junctions. The palatal shelves were dissected on either side of the midline. The eye was 300 dissected and the RPE peeled off mechanically from its posterior surface (facilitated by the dark 301 pigmentation of the RPE allowing straightforward visualisation). 302
Tissues were gently teased apart before cross-linking in 1% formaldehyde for 10 min at room 303 temperature. Fixation was quenched with 125 mM glycine for 5 min at room temperature before 304 centrifugation, removal of the supernatant and washing twice with 1 ml PBS. The final PBS 305 supernatant was discarded and samples stored at -80 °C until use ( Supplementary table 1 
). 306
Chromatin immunoprecipitation (ChIP), RNA isolation and sequencing 307 All ChIPseq datasets were in biological replicate except for stomach and tongue (Supplementary 308 table 1). Each sample was placed in lysis buffer [10 mM HEPES, 0.5 mM EGTA, 10 mM EDTA, 309 0.25% Triton X-100 and protease inhibitor cocktail (Roche)] on ice for 5 min and nuclei released 310 with 10 strokes in a Dounce homogeniser. Nuclei were pelleted by centrifugation at 700 rcf for 10 311 min at 4 °C and the supernatant discarded. Nuclei were resuspended in ice cold wash buffer (10 312 mM HEPES, 0.5mM EGTA, 1 mM EDTA, 20 mM NaCl and protease inhibitor cocktail) then 313 pelleted by centrifugation at 700 rcf for 10 min at 4 °C and the supernatant discarded. Nuclei were 314 lysed (50 mM Tris HCl, 10 mM EDTA, 1% SDS and protease inhibitor cocktail) and sonicated 315 under prior optimised conditions (Diagenode Bioruptor). Sufficient sample was prepared to allow in 316 parallel immunoprecipitation for H3K4me3, H3K27ac and H3K27me3 to minimise technical 317 variation. 1 g DNA equivalent was used for each pulldown. Samples were diluted with 9 volumes 318 of dilution buffer (16.7 mM Tris-HCL, 1.2 mM EDTA, 167 mM NaCl, 0.01% SDS and 1.1% Triton 319 X-100). 20 l ChIP grade magnetic beads were washed twice in dilution buffer and incubated with 320 each sample for 3 h on a tube rotator at 4 °C to preclear the sample. The beads were separated and 321 the pre-cleared lysate transferred to a separate tube. The magnetic bead pellet was discarded. For 322 each histone modification 3 g of antibody ( Supplementary table 1) (Supplementary figure 7) . 340
RNAseq for this study has been described previously 15 ; using identical methodology, we added 341 single datasets for pancreas and tongue and two datasets for lung to create biological transcriptomic 342 replicates for all tissues (Supplementary table 2) . 343
Mapping of ChIPseq and RNAseq
344
The first batch of ChIPseq was mapped originally to hg19 using Bowtie 1.0.0 (parameters -m1 -345 n2 -l28, uniquely mapped reads only) 36 based on rank profiles of read counts 3 kb either side of the TSS. The returned clusters were then 360 classified according to characteristics detected in both replicates: 'Actively repressed' (H3K27me3 361 signal >50% of maximum and mean transcript counts <10% of maximum); 'Narrow expressed' 362 [H3K4me3 signal >25% of maximum with > 90% of reads downstream of the TSS and skew >0.65 363 (measured across 100 equidistant percentiles from TSS to +3 kb); and mean transcript counts >10% 364 of maximum]; 'Broad expressed' (as for 'Narrow expressed' but with skew <0.65); 'Bi-directional 365 expressed' (H3K4me3 signal >25% of maximum with <90% of reads downstream of the TSS; and 366 mean transcript counts >10% of maximum); 'Bi-dir2' (as for 'Bi-directional expressed' but without 367 the H3K4me3 signal); 'Expressed2' (H3K4me3 signal >25% of maximum with mean transcript 368 counts <10% of maximum); and 'Inactive' (<25 of maximum for H3K4me3 and H3K27me3 and 369 mean transcript counts <10% of maximum). This approach left each gene uniquely assigned to one 370 cluster in any tissue. 'Bi-dir2' was only identified in RPE (Supplementary figure 2) . 'Expressed2' 371 was detected in lung, liver and brain (Supplementary figure 3) . While superficially this category 372 lacked significant transcription, in fact, total gene-level read counts were very similar to 'Broad 373 expressed'. However, longer mRNA and longer first introns limited transcript detection at the TSS 374 (Supplementary figure 4) . The full listings are in Supplementary table 3.  375 The over-representation of TFs in the TSS regions marked with H3K27me3 and featuring CpG 376 islands was assessed on the dataset of 1,659 genes encoding all the TFs compared against the 377 remaining 18,132 non-TF genes using Fisher's exact test (two-sided). 378
Alluvial plots were created using the R package Alluvial Diagrams version 0.2-0 40 with 379 modification of the R code to reorder the horizontal splines (alluvia) within each tissue to keep 380 similar colours together. 381
Transgenic analysis in zebrafish
382
A systematic approach identified candidate enhancers that were human embryo-enriched and 383 tissue-specific. We identified marks from the first batch of H3K27ac with RPKM > 25 and > 2.5-384 fold enrichment in the human embryo compared to ENCODE (7 cell lines) 23 or NIH Roadmap 385 datasets (154 tissues, including fetal datasets from the second trimester) 10 ; and that were undetected 386 in the FANTOM5 project 24 . To filter these embryonic marks for tissue specificity an initial dataset 387 was selected at random and peaks called that were > 200bp. The H3K27ac datasets from other 388 embryonic tissues were then overlaid sequentially in random order. Only called peaks > 200 bp 389 were included. After each addition, any peaks with < 50% overlap between the new and existing 390 dataset were retained. For those retained regions overlapping sequence was filtered out. Once 391 completed, the final set of human embryo-enriched, tissue-specific sequences were again filtered for 392 regions >200 bp. Re-running the tissue specificity algorithm for random addition of datasets 393 resulted in a 99.6% match to the first analysis. These candidate enhancer regions were filtered for 394 sequence conservation (PhastCons LOD score >50) 41 and correlated with surrounding transcription 395 (<1 mb in either direction). We manually inspected the remainder for proximity (<1 mb) to genes 396 encoding TFs associated with major developmental disorders and ensured no H3K4me3 or 397 polyadenylated transcription in the immediate vicinity (i.e. an unannotated promoter). This resulted 398 in 44 candidate enhancers from which we tested ten. The candidate sequences were first cloned in 399 TOPO vector using pCR8/GW/TOPO TA cloning kit (Catalogue number K252020, Invitrogen Downsampling of read counts to the 99 th percentile was used to generate the custom 'elbow' 425 threshold that called bins as marked or not for subsequent downstream analyses. When read counts 426 were ordered and plotted by rank the resulting graph was typically exponential with most bins 427 having zero or very few reads (below the elbow threshold) and a small number of bins with very 428 high read counts (above the elbow threshold). The elbow was defined as the point on the line with 429 the shortest Euclidian distance to the maximum rank intercept with the x-axis. Our code 430 (arseFromElbow) to determine these thresholds from a vector of counts is available on github 46 . Phi 431 correlation was used to measure the agreement between tissue replicates called by the 1 kb binning 432 method compared to MACS 37 . Hierarchical clustering of datasets was undertaken to assess potential 433 genes. The example shown is for adrenal. One replicate is shown for each data-type for simplicity. 606
Replicates across all tissues were near identical. Two minor variations on this pattern were detected 607 in RPE (Supplementary figure 2) and liver, lung and brain (Supplementary figure 3) 
647
a) Elbow plots for each histone modification following allocation of the genome into 3.1 million 648 consecutive bins of 1 kb. The example shown is for adrenal providing the number of reads per bin 649 at the point of maximum gradient change (the 'elbow point', red dot) and a quantitative measure of 650 whether a bin was marked or not (e.g. >10 or <10 respectively for H3K27ac). Converting marks 651 into a binary 'yes/no' call at any point in the genome facilitated data integration across the different 652 tissues. While the number of reads per bin at the elbow point was different for each mark across the 653 tissues the shape of the curve remained the same. b) Euler grid for bins marked by H3K27ac 654 
707
Pie charts for individual tissues of genome coverage according to chromatin state by ChromHMM. 708
The average for all tissues is shown in Figure 1c . 709 
712
In RPE the 'broad' and 'narrow' expressed categories identified in most tissues and shown in 713 Figure 2a were aggregated by ngsplot and termed 'broad/narrow' expressed. This occurred in 714 favour and as a consequence of clustering a subset of genes with less robust bidirectional 715 transcription and barely any marking for H3K4me3 or H3K27ac (termed 'Bi-dir2'). 716
